Association of hematologic biomarkers and their combinations with disease severity and mortality in COVID-19- an Indian perspective

Pujani, M.; Raychaudhuri, S.; Verma, N.; Kaur, H.; Agarwal, S.; Singh, M.; Jain, M.; Chandoke, R. K.; Singh, K.; Sidam, D.; Chauhan, V.; Singh, A.; Katarya, K.

Pujani, M.; Raychaudhuri, S.; Verma, N.; Kaur, H.; Agarwal, S.; Singh, M.; Jain, M.; Chandoke, R. K.; Singh, K.; Sidam, D.; Chauhan, V.; Singh, A.; Katarya, K..

American Journal of Blood Research ; 11(2):180-190, 2021.

Article in English | EMBASE | ID: covidwho-1431588

ABSTRACT

ABSTRACT

Background:

COVID-19 is a systemic viral infection with a significant impact on the hematopoietic system, hemostasis as well as immune system. It would be of utmost importance to explore if the most routinely used tests could serve as an aid in determining patient’s clinical status or predicting severity of the disease.

Methods:

A pro

Search on Google

XML

Collection: Databases of international organizations Database: EMBASE Type of study: Prognostic study Language: English Journal: American Journal of Blood Research Year: 2021 Document Type: Article

Similar

MEDLINE

LILACS

LIS

Search on Google

XML